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Fig. 1. Cystoscopy revealed an isolated nodular
tumor 11 millimeters in diameter.
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Plasmacytoid variant bladder cancer is a highly malignant subtype associated with a high propensity for
invasion, metastasis and poor prognosis. Among approximately 100 reported cases, most were diagnosed at
an advanced stage and only 10 were diagnosed at a non-muscle-invasive stage. Due to the limited data on
clinical features of non-muscle-invasive plasmacytoid variant bladder cancer, its treatment has not been
established. We report a long-surviving patient with pT1 plasmacytoid variant bladder cancer in whom the
bladder was conserved after detailed pathological examinations of the transurethral resection (TUR)
specimen and intensive follow-up. A 65-year-old man presented with macroscopic hematuria. Cystoscopy
revealed a nodular tumor 11 millimeters in diameter and no metastasis was observed on computed
tomography. The histopathological diagnosis of the TUR specimen was pT1 plasmacytoid variant
urothelial carcinoma of the bladder. Microvascular invasion was not found by immunohistochemical
staining and histopathological examination of the specimen from the second TUR indicated no residual
cancer. The patient strongly desired bladder conservation and additionally underwent intravesical
instillation therapy with 40 mg of mitomycin C weekly for 6 consecutive weeks. Follow-up cystoscopy
demonstrated 3 small papillary tumors 12 months after intravesical instillation therapy, but histopath-
ologically, the recurrent tumors were pTa with pTis urothelial carcinomas without plasmacytoid components.
To treat pTis disease, he subsequently underwent intravesical BCG instillation therapy. The plasmacytoid
variant bladder cancer has not recurred for 26 months since the initial diagnosis. Non-muscle-invasive and
localized plasmacytoid variant bladder cancer may be treated with bladder conserving therapy.
(Hinyokika Kiyo 64 : 369-372, 2018 DOI : 10.14989/ActaUrolJap_64_9_369)






















variant，high grade，pT1 で，HE 染色で通常の尿路上
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Fig. 2. HE staining (× 600). The plasmacytoid
variant cells had strongly eosinophilic cyto-




Fig. 3. Immunohistochemical studies of E-cadherin
and CD138 (×200). A : Urothelial carci-
noma cells were positive for E-cadherin.
B : Plasmacytoid variant cells were negative











について D2-40 および CD34 による免疫組織化学染
色で追加検索した．脈管浸潤は陰性との結果であった















その標本の組織診断結果は plasmacytoid variant の成分
は認めず，通常の尿路上皮癌 pTa および pTis であっ
た．Plasmacytoid variant を含まない通常の膀胱上皮内
















variant 成分のみ E-cadherin の消失を認めた．病理学
的にはこの E-cadherin の消失が plasmacytoid variant の
高い浸潤性や転移性の原因の 1 つと考えられてお
り3,6)，膀胱全摘術を施行した症例の報告によると，
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1 Coyne JD9), 2006 74 M T1NxMx NA NA Alive with disease
2 Coyne JD, 2006 74 F T1NxMx NA NA Alive with disease
3 Shimada10), 2006 46 M T1N0M1 (bone) Chemotherapy, radiotherapy 8 Died of disease
4 Fritshe3), 2008 79 M
≦ T1NxMx (E-cadherin
negative)
BCG, repeat resection of the
tumor base 18 Alive without disease
5 Ro11), 2008* 79 M T1 (multiple) N0Mx BCG 47 Alive with disease
6 Nigwer4), 2009 65 M T1N1M0 Cystectomy 43 Died of disease
7 Nigwer, 2009 79 M T1NxM1 (NA) Biopsy 4 Alive with disease
8 Nigwer, 2009 64 M T1NxMx TURBT 8 Alive with disease
9 Hayashi12), 2011 76 M
T1 (solid, diameter 2. 5
cm) N0M1 (brain)
TURBT, metastasectomy, adju-
vant MVAC (3 cycles) 96 Alive without disease
10 Present case 65 M T1N0M0 TURBT, MMC, BCG 24 Alive without disease
NA : not available.













を認めたが，病理学的に plasmacytoid variant 成分はな
く通常の膀胱癌の非浸潤性再発のみと判断した．
自験例は初発時，病理学的に CIS を伴わない 11
mm 径の単発腫瘍であり EORTC 分類の再発および
進行リスクはともに中間リスクに該当した13)．原発
巣の診断時には D2-40 および CD34 による免疫組織
化学染色を追加し，脈管浸潤なしと診断した．さらに
second TURBT で癌細胞の残存を認めず，画像検査で
転移を認めなかったため，N0 かつ M0 の膀胱限局性
癌と診断した．患者希望も考えた上で膀胱温存の方針
とした．結果として，26カ月の生存が得られた．
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